SUMMARY
To investigate the cell-intrinsic aging mechanisms that erode the function of somatic stem cells during aging, we have conducted a comprehensive integrated genomic analysis of young and aged cells. We profiled the transcriptome, DNA methylome, and histone modifications of young and old murine hematopoietic stem cells (HSCs). Transcriptome analysis indicated reduced TGF-b signaling and perturbation of genes involved in HSC proliferation and differentiation. Aged HSCs exhibited broader H3K4me3 peaks across HSC identity and selfrenewal genes and showed increased DNA methylation at transcription factor binding sites associated with differentiation-promoting genes combined with a reduction at genes associated with HSC maintenance. Altogether, these changes reinforce HSC self-renewal and diminish differentiation, paralleling phenotypic HSC aging behavior. Ribosomal biogenesis emerged as a particular target of aging with increased transcription of ribosomal protein and RNA genes and hypomethylation of rRNA genes. This data set will serve as a reference for future epigenomic analysis of stem cell aging.
INTRODUCTION
The function of the hematopoietic system declines with age, manifested by a decreased adaptive immune response and an increased incidence of myeloproliferative diseases, autoimmune, and inflammatory disorders (Linton and Dorshkind, 2004; Ramos-Casals et al., 2003) . Although some extrinsic cellular factors such as an inflammatory microenvironment promote aging (Ergen et al., 2012; Villeda et al., 2011) , these impact the hematopoietic stem cells (HSCs), causing cellintrinsic changes that affect the generation of a balanced supply of differentiated blood lineages.
Multiple lines of investigation have established that, with age, phenotypically defined mouse and human HSCs increase in number, whereas lymphoid cell production is diminished, leading to a myeloid-dominant hematopoietic system (Chambers et al., 2007b; de Haan and Van Zant, 1999; Morrison et al., 1996; Rossi et al., 2005) . The myeloid dominance is caused partly by a shift in the clonal composition of the HSC compartment (Beerman et al., 2010; Challen et al., 2010; Cho et al., 2008) but also reflects diminished differentiation capacity of individual HSCs (Dykstra et al., 2011) .
Mechanisms proposed to account for the age-related loss of HSC function include telomere shortening, accumulation of nuclear and mitochondrial DNA damage (Wang et al., 2012) , and coordinated variation in gene expression. Analysis of young and old HSCs revealed that genes associated with inflammation and stress response were upregulated, and genes involved in DNA repair and chromatin silencing were downregulated with HSC aging (Chambers et al., 2007b; Rossi et al., 2005) . These earlier studies were conducted on HSC populations that proved to be heterogeneous and therefore represented a mix of cellular phenotypes. Here, we examined highly purified HSCs and tested whether the concept that loss of epigenetic regulation of gene expression in aged HSCs could explain the constellation of aging phenotypes. We completed genomewide comparisons of the transcriptome (RNA sequencing [RNA-seq] ), histone modification (chromatin immunoprecipitation sequencing [ChIP-seq]) , and DNA methylation between young and old purified murine bone marrow HSCs. This report presents an integrated analysis of these genomic properties, reveals potential mechanisms that contribute to HSC aging, and offers a comprehensive reference epigenome of a somatic stem cell type. Finally, it reveals similarities with some common hallmarks of aging (Ló pez-Otín et al., 2013 ) previously noted in model organisms such as Caenorhabditis elegans and Drosophila melanogaster but not yet examined in mammals.
RESULTS

Alterations in Gene Expression with Age
Because previous analyses of gene expression changes with age utilized HSC populations that are now known to be heterogeneous with regard to lymphoid versus myeloid production proficiency, we utilized the most primitive HSCs with the highest long-term self-renewal potential, which are considered myeloid biased (or lymphoid deficient). HSCs throughout this study were purified as side population (SP)-KLS (c-kit + , lineage -, and Sca1 + )-CD150 + (see the Experimental Procedures) because these are found in both young and aged mice and have high phenotypic homogeneity and functional activity (Challen et al., 2010; Mayle et al., 2013) . High-throughput sequencing of poly A + RNA (RNA-seq) from purified 4-month-(4mo) and 24 month-old (24mo) HSCs was performed. With biological duplicates, more than 200 million reads in total for each age of HSC were obtained, offering high sensitivity for detecting gene expression differences in young and aged HSCs.
Comparison of the young and old HSC transcriptomes revealed that 1,337 genes were upregulated and 1,297 were downregulated with HSC aging (false discovery rate [FDR] < 0.05; Table S1 available online). Aging HSC hallmark genes Clusterin (Clu) and P-selectin (Selp) (Chambers et al., 2007b) were markedly upregulated, although their expression was also detectable in in young HSCs, demonstrating the sensitivity of RNA-seq.
Gene ontology (GO) analyses indicated that genes upregulated in 24mo HSCs are highly enriched in categories related to cell adhesion, cell proliferation, and the ribosome, whereas downregulated genes are enriched in DNA base excision repair, DNA replication, and cell cycle ( Figure 1A) . Gene set enrichment analysis with the Molecular Signature Database as well as several customized HSC, myeloid, and lymphoid gene sets (''fingerprint'' genes; Table S2 ) (Chambers et al., 2007a) revealed that HSC-specific genes as a group were upregulated in old HSCs, in agreement with their increased phenotypic stem cell characteristics. Cell cycle, DNA replication, and glutamate signaling were also differentially expressed gene sets.
The Aging HSC Transcriptome Suggests Reduced TGF-b Signaling Next, we sought to infer the key regulators responsible for transcriptional changes in aging HSCs. We performed a functional enrichment analysis on the basis of expected causeeffect relationships between transcriptional regulators and their targets in the Ingenuity Pathway Analysis (IPA) database. The most highly represented upstream regulator was growth factor TGF-b1, accounting for $19% of differential gene expression in young versus old HSCs (p = 1.96 3 10 À33 ; Table S3 ). In comparison to all genes affected by age, TGFb-regulated genes were five times more likely to be altered in expression than expected by chance (p = 3.53 3 10 À20 ). As a group, 63% (136 of 217) of TGF-b1 downstream genes were associated with a diversity of biological functions supporting hematopoiesis (n = 83, p = 4.56 3 10 À24 to 1.29 3 10 À9 ) and/or are corroborated by earlier microarray-based studies of HSC aging (n = 86; Table S3 ). Depending on the context, TGF-b factors exert pleiotropic, and sometimes opposing, cellular effects. If TGF-b1 signaling were inhibited, then we would expect key intermediary transcription factors (TFs) to be similarly affected. To test this, we constructed a network of cooperating regulators that are connected downstream of TGF-b1 by one edge. This analysis identified Smad3, Sp1, and Egr1 and predicted that they were inhibited during HSC aging ( Figure S1 and Table S3 ). Indeed, expression of Egr1, a regulator of HSC homeostasis (Min et al., 2008) , is significantly reduced with aging. Additional groups of genes normally activated by TGF-b are of interest. Seven collagen and three metalloproteinase (mmp) genes, implicated in HSC-niche interactions, were downregulated. In addition, expression of TGF-b-regulated genes involved in HSC development, such as Nr4a1, Cepba, Jun, and Junb, was reduced. Reduction of several of these targets could contribute to myeloid differentiation bias.
Of genes upregulated with aging, one notable class was ribosomal protein genes, including a majority of those encoding both the large (Rpl) and small (Rps) subunits ( Figure 1B ), but not mitochondrial ribosomal protein groups (Mrpl and Mrps; confirmed by exon arrays; Figure S2A ). Upregulation of genes involved in protein synthesis has been previously noted with aging. Indeed, inhibition of ribosomal proteins or their regulators has been shown to extend lifespan in yeast and worms (Kaeberlein et al., 2005; Syntichaki et al., 2007) . However, changes in the expression of ribosomal protein genes have not been previously reported in mammalian stem cells.
Expression of Key Epigenetic Regulators Decreases with Age
Because we hypothesized that epigenetic regulation plays a role in HSC aging, we examined expression of epigenetic modifiers ( Figure 1C ). Ezh1 showed increased expression, consistent with previous findings (Hidalgo et al., 2012) . In contrast, Ezh2 and the polycomb group (PcG) complex member Cbx2 decreased in old HSCs. In addition, expression of histone kinase genes Aurka and Aurkb, putative Ezh2 partners, or targets (Kamminga et al., 2006 ) also decreased with age.
Genes encoding DNA methyltransferases as a group decreased during aging (FDR = 0.02; Figure 1C and Table S2 ). Concomitantly, genes encoding Tet1 and Tet3 DNA demethylation proteins were also decreased. Although their functions are unknown, Tet2 mutation leads to expansion of hematopoietic progenitors and increased stem cell self-renewal (Ko et al., 2011; Li et al., 2011; Moran-Crusio et al., 2011; Quivoron et al., 2011) , and TET2 is recurrently mutated in myelodysplastic syndrome (MDS) and acute myeloid lymphoma (AML) patients (Delhommeau et al., 2009; Langemeijer et al., 2009 ). Consistent with reduction of Tet gene expression, quantitative mass spectrometry revealed reduced 5-hydroxymethycytosine with age ( Figure 1D ).
Repetitive elements are epigenetically repressed, so we examined whether they were dysregulated with aging. Strikingly, the RNA-seq data revealed marked changes in the expression of Figure 1E ). Anomalous repetitive element expression has been associated with embryonic stem cells (ESCs) (Xie et al., 2013) but not aging. Examination of the genes near the dysregulated LTR elements, LINEs, and SINEs revealed 194, 127, and 72 genes, respectively. Functional enrichment with the Genomic Regions Enrichment of Annotations Tool indicated LINE-and SINE-associated genes were enriched for these involved in hematological diseases such as Cdc42, Flt3, and Lmo2 (Table S4 ).
Alterations in Transcript Isoform Expression
RNA-seq also revealed age-associated changes in promoter usage and pre-mRNA abundance. We identified 118 genes that showed switched promoter usage during aging (Table S4) . One example is Runx1t1, a locus translocated to RUNX1 in some types of AML. The full-length Runx1t1 is expressed in old HSCs, and the short isoform is expressed in young HSCs ( Figure S2B ). Another example is Nfkbiz, with expression of the short isoform decreased with aging ( Figure S2C ). We previously noted that HSCs contain significant incompletely spliced mRNA that is reduced when HSCs are activated (Venezia et al., 2004) . Global pre-mRNA quantification confirmed a full 13% of reads within RefSeq introns in young HSCs, which decreased with age ( Figure S2D ). Nearly 300 genes showed ageassociated alteration of pre-mRNA abundance. Of the 184 genes with decreased pre-mRNA abundance, many were classified in ribosome, immunoglobulin domain, and extracellular region categories by GO analysis (for example, Ctla2a and ribosome protein Rpl13; Figure S2E ), whereas the 96 genes with increased pre-mRNA were enriched in zinc-finger-encoding genes (Figure S2F) . The decreased pre-mRNA with age may be associated with increased translation.
HSC-Specific Chromatin Features
To examine epigenetic alterations, we profiled the principal regulatory chromatin marks in HSCs, specifically H3K4me3, H3K27me3 and H3K36me3 marks in young (4mo) and old (24mo) HSCs with the use of ChIP-seq. Because these global analyses have never been performed on such highly purified HSCs, we first describe our general observations.
In young HSCs, 10,263 RefSeq genes had clear H3K4me3-associated peaks. Clustering of the signal around the transcription start site (TSS) show that the H3K4me3 peaks can be classified into four distinct clusters ( Figure 2A ). Cluster 1 overlaps with 2,373 genes and shows high intensity and wide coverage (mean 3,200 bp) into the gene body. Cluster 2 (2,225 genes) and cluster 3 (5,665 genes) have similar intensity and coverage lengths ($2,000 bp), but cluster 2 has more coverage upstream of the TSS. The remaining RefSeq genes have little or no discernible H3K4me3 peak (cluster 4).
For the repressive H3K27me3 mark in young HSCs, we identified 3,768 peaks present in the promoter region defined as the TSS ± 1 kb. Unsupervised clustering showed the majority with a sharp peak over the TSS (cluster 2; distinct from the H3K4 clusters). A small subset showed high levels spread over most of the coding region (cluster 1; Figure 2B ). For H3K36me3, the signals are depleted at the TSS and increase from the TSS to the transcription termination site ( Figure 2C ). As in other cell types, this mark was strongly correlated with gene expression and enriched in the gene body. H3K36me3 and H3K27me3 signals were generally mutually exclusive ( Figure S3A ).
Genes with both activating H3K4me3 and repressive H3K27me3 were first identified in ESCs as so-called ''bivalent'' genes, thought to represent poised master regulators (Bernstein et al., 2006) . Here, 2,267 out of 3,768 H3K27me3-enriched genes in HSC also contain H3K4me3 ( Figure 2D ), similar to the proportions in ESCs (although we cannot confirm that the marks are on the same allele). These genes were enriched for development, transcriptional regulation, and RNA metabolism GO categories ( Figure 2E ), consistent with previous observations (Weishaupt et al., 2010) . Many transcription factors important for hematopoietic differentiation, such as Cebpa, Ebf-1, Pax5, and Gata3, appeared bivalent. Notably, one-third of the bivalent HSC genes are glycoproteins involved in signaling pathways such as Wnt, Hedgehog, bone morphogenetic proteins, and TGF-b. Their expression was generally low ( Figure S3B ).
Next, we attempted to identify potential HSC regulators on the basis of histone modifications. We compared ESC H3K4me3 and H3K27me3 binding sites (Bernstein et al., 2006) with those from HSCs as well as differentiated B cells and granulocytes (Gr) ( Figure 2F ). We selected genes that were developmental regulators (bivalent in ESCs) and were activated in HSCs (H3K4me3 only) but were repressed upon HSC differentiation (regained H3K27me3 in differentiated B cells and Gr) to identify 255 genes ( Figure 2G and Table S5 ). These are enriched for TFs and pathways in cancer ( Figure S3C ). Significantly, 20% of them overlap with HSC fingerprint genes (Chambers et al., 2007a) , including Cd34, Gata2, and Meis1, whose functions in HSCs have been demonstrated, showing that histone profiles can independently predict key HSC regulators.
Aging-Associated Changes in Histone Marks
Next, we examined aging-associated histone mark changes. Although most shifts were moderate, there were some unique features. Old HSCs exhibited a 6.3% increase in the number of H3K4me3 peaks, many of which were considerably broader with age; more than half of all H3K4me3 peaks expanded, and less than 10% shrank ( Figure 3A ). The expansion of H3K4me3 coverage was greatest for peaks already broad in young HSCs; for peaks longer than 3 kb in young HSCs, there are 69% and 7% of lengthening and shortening events, respectively 
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Epigenome Dysregulation in Aging HSCs ( Figure S3D ). Peak expansion was particularly striking at genes associated with HSC identity ( Figure S3E ). More H3K4me3 coverage in old HSCs suggested that some previously unexpressed transcripts are activated. The levels of H3K4me3 were significantly increased on 267 promoters and decreased on 73 promoters in the old HSCs ( Figure 3B ). We observed a strong positive correlation between altered H3K4me3 signal and gene expression changes ( Figure 3C ). Increased H3K4me3 was observed for the most upregulated genes, such as Selp, Nupr1, Sdpr, Plscr2, and Slamf1, and genes in the HoxB cluster ( Figure S3F ). In addition, increased H3K4me3 was associated with altered promoter usage, for example, at the oxidation resistance 1 (Oxr1) gene, revealing an unannotated promoter ( Figure 3D ).
PcG-mediated epigenetic alteration is considered a driving force behind many age-related changes and is often dysregulated in human malignancies. We observed similar H3K27me3 peak counts with age but increased length of coverage by 29% from 203 to 261 Mb, and the average signal intensity at the TSS increased by $50%, similar to quiescent satellite cells (Liu et al., 2013) . H3K27me3 binding increased at 402 promoters and decreased at 124 promoters ( Figure 3E) . Notably, at the Flt3 locus, H3K27me3 was increased and expression decreased ( Figure S3G ), consistent with the diminished lymphoid differentiation potential of aged HSCs.
One well-known target of the PcG family during aging is Cdkn2a (encoding p16 INK4a ), which showed progressive loss of H3K27me3-associated repression and increased expression with aging in neural stem cells (Molofsky et al., 2006) . Increased Cdkn2a is considered a primary indicator of cellular senescence in virtually all tissues in mice and humans (Ló pez-Otín et al., 2013). However, HSCs represent a stark exception; our results show that p16
INK4a is a bivalent gene effectively repressed by H3K27me3 in both 4mo and 24mo HSCs, and its expression remains undetectable at either age ( Figure S3H ). These data argue against the notion that loss of function of HSCs with age is due to the acquisition of a senescent state linked to p16. Considering the global changes of H3K4me3 and H3K27me3 with HSC aging, we reexamined the bivalent domains. The results indicated that 335 bivalent domains disappear in old HSCs, whereas 1,245 emerge, largely because a gain of both H3K4me3 and H3K27me3 or H3K27me3 only ( Figure 3F ). The genes that lose H3K27me3 are enriched for the category of membrane protein, whereas the genes that gain H3K27me3 are enriched for glycoprotein and cell adhesion ( Figure S3I and Table S5 ).
HSC-Specific Methylome
We also examined DNA methylation changes with aging. Global CpG hypomethylation associated with aging has been observed in many tissues and is thought to contribute to genome instability and the risk of neoplastic transformation (Maegawa et al., 2010) . Here, we used whole-genome bisulfite sequencing (WGBS) and generated 1,494 million (4mo HSCs) and 1,493 million (24mo HSCs) reads; about 82.6% and 84.3%, respectively, were aligned to the reference genome (mm9). Of all cytosines present in the reference genome, about 93% of Cs and 99% of CGs were covered in both data sets, with an average coverage of 46-fold (4mo) and 50-fold (24mo).
Globally, the HSC methylome exhibited the DNA methylation patterns in line with those observed in other mammalian cells (Stadler et al., 2011) . Low DNA methylation was found in CpG islands (CGIs) and promoters, and high methylation was found in gene bodies and repetitive elements ( Figures 4A and S4A-S4C ). Bivalent domains showed the lowest DNA methylation (5%; Figure S4D ), which was consistent with the inverse correlation of DNA methylation and H3K4me3 (Meissner et al., 2008) . In contrast, H3K36me3-enriched regions are associated with the highest DNA methylation (94%), possibly because of Dnmt3a and H3K36me3 interaction (Dhayalan et al., 2010) . Interestingly, the CGI methylation is diverse and dependent on the genomic or epigenomic context ( Figure S4E ).
We also compared the HSC and ESC (Stadler et al., 2011) methylomes. 5% of CGIs show differential methylation between these two stem cell types, with 689 CGIs hypermethylated and 130 CGIs hypomethylated in HSCs ( Figure 4B ). Furthermore, we identified differentially methylated regions (DMRs) between HSCs and ESCs as a region of at least 100 bp in length wherein consecutive CpGs show the same hyper-or hypomethylation state. Analysis showed striking enrichment of positive TF regulation for hypo-DMR genes and negative TF regulation for hyper-DMR genes. Of ten well-known hematopoietic TFs (Wilson et al., 2010) , all had hypomethylated promoter regions, and their target binding sites were also hypomethylated. For example, the Runx1 promoter is methylated in ESCs and unmethylated in HSCs ( Figure 4C ), and its binding sites showed a strong bias toward hypomethylation in HSCs ( Figure 4D ). Altogether, the general methylation pattern in different genomic regions is conserved in HSCs, but the methylation of cell-typespecific TFs and their binding sites is unique to HSCs.
Aging-Dependent DNA Methylation and Interaction with Histone Modifications
In contrast to the age-associated hypomethylation observed in somatic cells, HSCs showed methylation increasing with age from 83.5% to 84.6% in old HSCs, which was consistent with previous studies focused on CGIs (Beerman et al., 2013) . We observed a total of 448,166 differentially methylated CpGs (DMCs; R20% difference), of which 38.5% were hypomethylated (hypo-DMCs) and 61.5% were hypermethylated (hyperDMCs). For different genomic features (Table S6) , a slightly greater DNA methylation increase was observed for the gene body, LINEs, and SINEs, whereas CGIs and promoters showed balanced increases and decreases ( Figure 5A ). DNA encoding for rDNA was a hotspot for hypo-DMCs ( Figure 5B ). CpGs with an intermediate methylation ratio were more susceptible to alterations than fully methylated or unmethylated CpGs (Figure S5A) . We also found that increased H3K4me3 strongly correlated with hypomethylation, H3K27me3 regions are hot spots for both hypo-and hyper-DMCs (Table S6) , and decreased H3K36me3 correlated with hypo-DMCs ( Figure 5C ).
To identify the genes or pathways subject to DNA methylation alterations, we screened the methylome for DMRs. We identified 4,828 hypo-and 4,523 hyper-DMRs between 4mo and 24mo HSCs that were associated with 2,253 and 2,071 genes, respectively (Table S7) . Calculating the Pearson correlation between the methylation and gene expression changes, we discovered that DMRs between the TSS and the 1 kb immediately downstream showed the highest correlation with gene expression (À0.312) followed by the DMRs in the promoters lacking CGIs (À0.250; Figure S5B ). Hypo-DMR-associated genes are enriched for pathways in cancer and include Bcl2, Ptk2, Rb1, Mll3, Runx1, Flt3l, Myc, Igf1, Igf1r, NFkb2, Tgfb3 , and Tgfbr2. In contrast, both hypo-and hyper-DMR genes are enriched in old HSCs for cell adhesion and actin cytoskeleton, such as Arpc1a, Ablim2, Cadm1, Cdh1, Col2a1, CD34, CD40, and CD86 ( Figure S5C and Table S7 ).
DNA hypermethylation on polycomb-targeted genes is a hallmark of cancer and aging. Here, we compared H3K27me3-marked genes in both young and old HSCs with the DMR gene list. We found that 40% of hyper-DMR genes contain H3K27me3 marks, whereas 25% of hypo-DMR genes contained H3K27me3, confirming that polycomb-targeted genes are hotspots for aging-related DNA methylation ( Figure 5D ). One example is Nr4a2, a regulator of HSC quiescence (Sirin et al., 2010), which gained methylation on the H3K27me3-marked domain with age and correlated with suppression of the short isoform ( Figure S5D ). To examine whether an epigenetic signature alone might identify potential biomarkers of aging, we identified $50 genes that showed concomitant DNA methylation and histone H3K4me3 differences during HSC aging ( Figure 5E ). These loci showed a particularly strong inverse correlation between their agerelated decrease in DNA methylation and their increased H3K4me3 (64%; Figure S5E ), but not all of them showed increased gene expression ( Figure S5F ). These results indicate that the epigenetic state may be used to predict aging independent of gene expression.
Aging-Associated DNA Methylation Interferes with the Transcriptional Network
Previous DNA methylation studies showed that hypomethylated regions are usually associated with cell-specific regulatory regions or TF binding sites (Hodges et al., 2011; Stadler et al., 2011; Ziller et al., 2013) . To determine whether the methylation states in such regulatory regions change with HSC aging, we examined the methylation ratio in the binding sites of five TFs associated with HSC pluripotency, including Scl, Erg, Gata2, Runx1, and Ldb1 (Wilson et al., 2010) . Although basal methylation levels for these TF binding sites in HSCs are low (Figure S6A ), methylation at Gata2 and Ldb1 binding sites are further reduced with age ( Figure S6B ). This led us to further test whether aberrant DNA methylation disrupts the HSC transcriptional networks more broadly. We compiled genome-wide binding sites of more than 150 TFs found in a variety of blood lineages (>10) and compared them with DMRs identified in young and old HSCs. The results revealed that hypo-DMRs are significantly enriched for Ring1b, Scl, Gata1, Ldb1, and Runx1 binding sites in old HSCs but not for Rad21 binding sites, which served as a 
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Epigenome Dysregulation in Aging HSCs negative control ( Figure 6A ). Combinatorial interactions of Scl, Lyl1, Gata2, Runx1, Lmo2, Fli1, and Erg have been suggested to form a central transcription network that regulates HSC pluripotency (Wilson et al., 2010) . Therefore, hypomethylation of the binding sites for some of these factors or related family members may play a role in reinforcing the self-renewal program in HSCs.
In parallel, hyper-DMRs are highly enriched for Pu.1, Fli1, Gfi1, and Erg binding sites in old HSCs ( Figure 6B ). Among them, binding sites of Pu.1, which promotes HSC differentiation, showed hypermethylation with the highest statistical significance (Figure 6C ). Given that mutation or deletion of PU.1 is leukemogenic (Cook et al., 2004) , hypermethylation of its binding sites may increase the risk for myeloid leukemia. We also examined changes with age in methylation of canyons, which comprise around 1,100 large regions with low methylation enriched for genes involved in transcriptional regulation (Jeong et al., 2014) . Hypomethylation is 25% to 28% more frequent at inner edges of canyons, whereas hypermethylation is 25% more frequent at outside edges ( Figure 6D ). Furthermore, canyons with more hypomethylated DMCs are associated with greater H3K4me3 coverage, whereas canyons with more hypermethylated DMCs show a distinct shift in H3K27me3 occupancy characterized by both a substantial decline in partial coverage (spanning < 25% of canyon length) and an increase in broader H3K27me3 coverage (spanning > 90% of canyon length; Figure 6E) . This is similar to the behavior of canyons after Dnmt3a KO (Jeong et al., 2014) .
All of these findings suggest that DNA methylation is a critical layer of epigenetic regulation controlling HSC aging and underscore some of the similarities between the epigenetic changes with aging and those in Dnmt3a knockout HSCs.
Methylation Alterations Identify HSC Regulators and Age-Associated Phenotypes
To determine whether changes in DNA methylation were likely to affect HSC function, we compared DMR genes with HSC myeloid and lymphoid fingerprint genes. Strikingly, of HSC fingerprint genes, 70% showed hypomethylation (Table S7) , which correlated with their increased expression (À0.45; Figures  7A and S7A ). Hypermethylation and decreased expression was also observed on a subset of HSC fingerprint genes. To test whether their decreased expression might explain HSC aging phenotypes, we selected the imprinted gene Slc22a3 encoding a solute carrier family member (Grü ndemann et al., 1998) , for further characterization ( Figure 7B ). To examine its function, we transduced progenitors from young mice with a retroviral microRNA (miRNA) knockdown construct. After 2 days of culture, transduced cells were sorted for quantitative RT-PCR (qRT-PCR) in order to confirm a knockdown efficiency of about 60% (Figure 7C ), mimicking its expression change in old HSCs. Although transplantation showed knockdown of Slc22a3 did not affect engraftment, there were a greater proportion of myeloid cells generated from Slc22a3 knockdown HSCs ( Figure 7D ). Thus, decreased expression of Slc22a3 may contribute to the myeloid-biased differentiation of old HSCs.
MDS is a hematologic disorder that increases dramatically with age. We considered whether some of the changes associated with normal HSC aging were associated with MDS. We examined 66 MDS-related genes as defined by IPA. Of these, 21 contained a DMR (p = 1 3 10 À16 ), and their methylation changes were generally inversely correlated with geneexpression changes ( Figure 7E ). Five contained both hypoand hyper-DMRs, such as Hspa1a ( Figure S7B) . Notably, the gene for splicing factor Sf3b1 contains a hyper-DMR at its TSS region and shows decreased expression. Somatic mutation of this gene has been found in 20% of MDS patients (Papaemmanuil et al., 2011) . The disordered methylation on those MDSassociated genes may contribute to the development of this disease.
DISCUSSION
In summary, we present a comprehensive report of the transcriptome and epigenetic signatures, including DNA methylation and three histone modifications, of highly purified young and old HSCs, which can serve as a resource for both normal and aging adult stem cell studies. The epigenetic alterations are closely correlated with the phenotypic and functional changes that have been documented for HSCs, namely the increased HSC self-renewal, diminished differentiation potential, and biased ratio of myeloid versus lymphoid differentiation. Although not directly pathological, the epigenetic changes we observe clearly provide a cellular environment conducive to age-related pathologies, such as MDS and leukemia, as outlined below.
Age-Related Changes Suggest Reduced TGF-b Signaling Our analyses of the transcriptome of young and old HSCs strikingly implicate TGF-b as likely to be among the most significant contributors to the functional age-related declines that occur in this stem cell type with age. Although decreased TGFb signaling has been implicated in aging of cardiac and neural tissue (Blaney Davidson et al., 2005; Loffredo et al., 2013) , we observed genes involved in specific signaling modules that are most likely mediating the altered TGF-b response. In the context of HSCs, we are inferring responses to stimuli that are most likely initiated by the niche based on the large number of dysregulated TGF-b genes.
For each step of the TGF-b1 signaling pathway, there are a number of differentially expressed genes in aging HSCs. For example, genes involved in ligand activation or bioavailability were decreased, such as matrix metalloproteases mmp-2 and mmp-9 (Yu and Stamenkovic, 2000) . We also observed decreased expression of the gene for Smad6, which interferes with phosphorylation of Smad2 (Imamura et al., 1997) and Smad cofactors p300, Crebbp, and Atf3. Given these data, as 
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Epigenome Dysregulation in Aging HSCs well as the long-standing evidence for a role in TGF-b signaling on HSC function (Fan et al., 2002; Jacobsen et al., 1995) , further study of the role of TGF-b signaling in HSC aging is warranted.
Significance of the Altered Ribosomal Gene Transcription
In the transcriptome, epigenome, and methylome data, we found that genes included in the GO category ribosome were a prominent target of aging. In particular, the decreased ribosomal protein gene pre-mRNA levels suggest more efficient splicing and possibly translation. Even though aged HSCs are not more in cycle than young HSCs (Chambers et al., 2007b; Rossi et al., 2005) , they may be more activated. Intriguingly, defects in ribosome biogenesis have been linked to bone marrow failure syndromes associated with a risk of developing malignancies, such as Diamond-Blackfan anemia (Narla and Ebert, 2010) . In addition, ribosomal biogenesis has repeatedly been linked to aging in model organisms (Curran and Ruvkun, 2007; Grewal, 2009; Hamilton et al., 2005; Pan et al., 2007) but not yet in mammals. Our data suggest that a reexamination of the role of the ribosome in mammalian stem cell aging should be undertaken.
Consistency of HSC Aging with General Organismal Aging
Our observations regarding the increase in H3K4me3 peaks and the increased length of many of the peaks is striking in the context of recent observations in C. elegans where mutation of genes involved in H3K4 methylation increased longevity (Greer et al., 2010) . This phenomenon was dependent on a histone demethylase (Greer et al., 2011) , indicating that sustained H3K4 methylation activity promotes aging. Although we do not identify loss or gain of H3K4 methyltransferases, the accumulation of H3K4me3 with age, particularly on genes in which H3K4 trimethylation is already broad, most likely contributes to the dysfunction of HSCs in the older animals. Notably, the genes associated with increased H3K4me3 breadth are specifically those associated with stem cell self-renewal and loss of differentiation capacity. Thus, the increase of this activating mark on these particular genes may be linked to the functional changes that occur in aged HSCs. We reanalyzed data from a recent study on aging of muscle satellite cells (Liu et al., 2013) and found that H3K4me3 length also increased by about 5% with age (data not shown). It will be important to extend these observations of H3K4me3 to other aging systems and identify the critical targets and mechanisms.
Relationship between Normal HSC Aging and Myeloid Malignancies MDS and AML are increasingly common with age. Although heterogeneous, both of these diseases are marked by impeded differentiation and a shift toward myeloid output. Our data suggest that, even in the absence of discernable mutations, aging HSCs acquire a host of changes that are consistent with a predisposition to MDS and myeloid malignancies. For example, we see that expression of genes for key the epigenetic regulators Dnmt3a and Ezh2 (both of which are found mutated in MDS and AML) are slightly but significantly downregulated with age.
We also see that HSC-specific genes such as Gata2 and Hmga2 are hypomethylated and upregulated and that binding sites of TFs associated with differentiation, such as Pu.1, tend to become hypermethylated, whereas sites associated with factors involved in stem cell function (e.g., Scl) tend to be hypomethylated. Finally, we showed that the edges of DNA methylation canyons are highly dynamic in a manner concordant with loss of Dnmt3a function (Jeong et al., 2014; Challen et al., 2012) , the mutation of which is associated with hematologic malignancies (Ley et al., 2010; Yan et al., 2011) . Although our data cannot distinguish cause and effect with regard to these epigenetic changes with age, together they point to a stem cell state in which self-renewal is reinforced and differentiation is impeded-a cellular milieu likely to be conducive to transformation events.
Abating the Effects of Age
By using whole-genome analyses, we showed that concerted epigenetic changes may contribute to decreased differentiation and increased stem cell self-renewal. These data also show that the impact of epigenetic changes on aging is consistent, suggesting the possibility that some of the effects might be abated. Although aging is often regarded as an inexorable and irreversible process, emerging views suggests that the aging clock can be experimentally manipulated. Altogether, the findings here may allow the development of novel approaches to modulate HSC function.
EXPERIMENTAL PROCEDURES Animals C57BL/6 male mice were purchased from the National Institute for Aging and maintained at the Baylor College of Medicine Animal Care Facility under International Animal Care and Use Committee and institutional guidelines. None of the animals exhibited overt signs of pathology when sacrificed. We chose 24 months because this time point presages significant mortality increase and healthspan decline.
HSC Purification and Flow Cytometry
HSCs were purified from bone marrow of mice either 4 or 24 months of age. For all experiments, HSCs were purified as Hoechst SP-KLS and CD150 + cells (see the Supplemental Experimental Procedures). Bone marrow cells were stained for 90 min with Hoechst, magnetically enriched for cells with c-expression, stained with additional antibodies, and then subjected to flow cytometric cell sorting. Purity was typically R 95%. Whole-Genome Bisulfite Sequencing 300 ng genomic DNA was isolated from HSCs and fragmented with a Covaris sonication system (Covaris S2). Libraries were constructed with Illumina TruSeq DNA kit, ligated, and bisulfite-treated with the EpiTect Kit (QIAGEN). After determining the optimized PCR cycle number for each samples, a large-scale PCR reaction (100 ml) was performed . PCR products were sequenced with Illumina HiSeq sequencing systems. The WGBS data analyses were based on the model-based analysis of bisulfite sequencing (http://code.google.com/p/moabs/).
RNA Sequencing
Statistical and Bioinformatic Analysis
See the Supplemental Experimental Procedures.
ACCESSION NUMBERS
Data sets were deposited to the NCBI Gene Expression Omnibus under accession number GSE47819. Data and genome browser tracks can also be found at http://www.aginghscepigenome.us. 
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